New SEC Form D filing

INFLAMMATIX, INC., 2026-11-19

A new SEC Form D private-offering notice from Sunnyvale, CA, a $57,272,732 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

INFLAMMATIX, INC. site↗ Verified via SEC Form D

Developer of host response molecular diagnostics for acute infection and sepsis, including the TriVerity blood test.

New filing todayFiled to raise $57,272,732First money in 2024-04-05Raised so far $47,421,597HQ (as filed) Sunnyvale, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Late filing
Source linked the Form D on EDGAR↗Website verified inflammatix.com↗Named in the filing 7 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source